Movie Industry

'Hope' Tops the Box Office for the 6th Consecutive Day… Cumulative Attendance Reaches 2.27 Million

"Spider-Man: Brand New Day" Tops Advance Ticket Sales

Choi Hee-jae
2026-07-21 08:23:06
[Edaily Starin Choi Hee-jae Reporter] Director Na Hong-jin’s new film “Hope” continues its box office success, remaining at the top of the box office charts for the sixth consecutive day since its release.
Poster for the movie “Hope” (Photo courtesy of Plus M Entertainment)

According to the Korean Film Council’s integrated computer network on the 21st, “Hope” drew 143,062 viewers on the 20th. Its cumulative audience count stands at 2,272,733.
Despite mixed reviews, “Hope” is maintaining its No. 1 position and dominating the box office.
Second place went to Universal Pictures’ “Minions & Monsters.” It added 16,807 viewers that day, bringing its cumulative total to 391,583. Disney’s “Moana” drew 11,094 viewers.
Following them, *The Pupil*, starring Shin Min-a, and Disney·Pixar’s *Toy Story 5* took fourth and fifth place, respectively, continuing their long-running success.
While “Hope” has maintained the No. 1 spot at the box office for six consecutive days, new releases are also poised to make their mark. As of 8:18 a.m. on the 21st, “Spider-Man: Brand New Day” secured 272,696 advance ticket sales ahead of its release, taking the top spot in advance ticket sales. Director Christopher Nolan’s new film, “The Odyssey,” ranks third with 73,864 advance ticket sales. “Hope” secured second place with 148,728 advance ticket sales.
With fierce competition expected in the summer box office, all eyes are on whether “Hope” can maintain its box office momentum.

Economy

Corporation

IT·Science

Economy

[Market In] E-Land World Moves to Issue 40 Billion Won in Corporate Bonds, Defying the BBB-Rating Downturn

E-Land World (BBB0) is set to issue up to 40 billion won in public corporate bonds. With investor sentiment toward BBB-rated corporate bonds currently subdued, all eyes are on whether the company can …
2026-08-07 18:54:04

Corporation

MedPacto, Inc. Adds Medium-Dose Group to Phase 2 Trial of Baekto-Seetip for Osteosarcoma… Files Application to Amend IND

(Photo courtesy of MedPacto, Inc.) MedPacto, Inc.(235980)is adding a medium-dose patient group to the Phase 2 clinical trial of “Vactosertib,” which it is developing as a treatment for osteosarcom…
2026-08-07 18:21:02

IT·Science

Coreline Soft Co., Ltd. Signs Contract for Lung Cancer Screening Project in Germany… A 10-Year “Jackpot”

Medical artificial intelligence (AI) company Coreline Soft Co., Ltd.(384470)announced on the 7th that it has secured a contract for a lung cancer screening project in Lostau, Germany, through Canon Me…
2026-08-07 18:44:02